David G. Gaiero

Insider Reports History

Location
Cambridge, MA
Signature
/s/ David Gaiero
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David G. Gaiero:

Form 4 holding Chief Financial Officer

Cyteir Therapeutics, Inc.

Security class
Common Stock
Shares / value
102,391
Estimated value
$173,041
Report date
04 Mar 2024
Price
$1.69
Ownership
Direct
Form 4 holding Chief Financial Officer

Cyteir Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
83,052
Estimated value
Report date
04 Mar 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chief Financial Officer

Imunon, Inc.

Security class
Common Stock
Shares / value
0
Estimated value
Report date
01 Jun 2024
Price
Ownership
Direct

Insider Reports Filed by David G. Gaiero

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .